These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 29280768)

  • 21. Update on HIV Testing, Management, and Prevention in Adolescents and Young Adults.
    Mullins TL; Lehmann CE
    Adolesc Med State Art Rev; 2014 Aug; 25(2):266-78. PubMed ID: 27132313
    [No Abstract]   [Full Text] [Related]  

  • 22. Race and the Public Health Impact Potential of Pre-Exposure Prophylaxis in the United States.
    Schneider JA; Bouris A; Smith DK
    J Acquir Immune Defic Syndr; 2015 Sep; 70(1):e30-2. PubMed ID: 25950209
    [No Abstract]   [Full Text] [Related]  

  • 23. Eliminating the HIV epidemic: the US government can make preexposure prophylaxis affordable now.
    Faustino E; Fielding J; Teutsch S
    AIDS; 2019 Oct; 33(12):1951-1952. PubMed ID: 31490216
    [No Abstract]   [Full Text] [Related]  

  • 24. Safer Conception Strategies for HIV-Serodiscordant Couples: How Safe Is Safe Enough?
    Ciaranello AL; Matthews LT
    J Infect Dis; 2015 Nov; 212(10):1525-8. PubMed ID: 26092857
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinical update.
    Haddow L; Herbert S
    Sex Transm Infect; 2015 Mar; 91(2):150. PubMed ID: 25698792
    [No Abstract]   [Full Text] [Related]  

  • 26. Users of a National Directory of PrEP Service Providers: Beliefs, Self-Efficacy, and Progress Toward Prescription.
    Bratcher A; Schlueter Wirtz S; Siegler AJ
    J Acquir Immune Defic Syndr; 2018 Aug; 78(4):e28-e30. PubMed ID: 29672350
    [No Abstract]   [Full Text] [Related]  

  • 27. Awareness, Willingness, and PrEP Eligibility Among Transgender Women in Rio de Janeiro, Brazil.
    Jalil EM; Grinsztejn B; Velasque L; Ramos Makkeda A; Luz PM; Moreira RI; Kamel L; Fernandes NM; Ferreira ACG; Hoagland B; Wagner S; Liu A; McFarland W; Buchbinder S; Veloso VG; Wilson E;
    J Acquir Immune Defic Syndr; 2018 Dec; 79(4):445-452. PubMed ID: 30142140
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Audit of patient retention in pre-exposure prophylaxis (PrEP) services in an integrated sexual reproductive health service setting.
    Cochrane E; Knapper C
    Int J STD AIDS; 2019 Dec; 30(14):1432-1435. PubMed ID: 31795927
    [No Abstract]   [Full Text] [Related]  

  • 29. Dean Street clinics-battling London's MSM HIV epidemic.
    Kirby T; Thornber-Dunwell M
    Lancet HIV; 2018 May; 5(5):e210. PubMed ID: 29739698
    [No Abstract]   [Full Text] [Related]  

  • 30. HIV Pre-exposure Prophylaxis Medication Sharing Among HIV-Negative Men Who Have Sex With Men.
    Mansergh G; Mayer K; Hirshfield S; Stephenson R; Sullivan P
    JAMA Netw Open; 2020 Sep; 3(9):e2016256. PubMed ID: 32915232
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increasing Access to Pre-Exposure Prophylaxis Among Transgender Women and Transfeminine Nonbinary Individuals.
    Klein A; Golub SA
    AIDS Patient Care STDS; 2019 Jun; 33(6):262-269. PubMed ID: 31166785
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Better late than never: PrEP in England.
    The Lancet Hiv
    Lancet HIV; 2017 Jan; 4(1):e1. PubMed ID: 28007341
    [No Abstract]   [Full Text] [Related]  

  • 33. Charlene Susan Dezzutti (1964-2018) Virologist with a Passion for HIV Prevention.
    Hillier SL; Cummins JE; Rohan LC
    AIDS Res Hum Retroviruses; 2018 Jun; 34(6):475-476. PubMed ID: 29888975
    [No Abstract]   [Full Text] [Related]  

  • 34. The current status of the use of oral medication to prevent HIV transmission.
    Mayer KH; Ramjee G
    Curr Opin HIV AIDS; 2015 Jul; 10(4):226-32. PubMed ID: 26049946
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Authors' Reply: Race and the Public Health Impact Potential of Pre-Exposure Prophylaxis in the United States.
    Cohen SE; Vittinghoff E; Doblecki-Lewis S; Coleman M; Bacon O; Elion R; Kolber MA; Buchbinder S; Liu AY
    J Acquir Immune Defic Syndr; 2015 Sep; 70(1):e33-5. PubMed ID: 26049284
    [No Abstract]   [Full Text] [Related]  

  • 36. Acceptability of Three Novel HIV Prevention Methods Among Young Male and Transgender Female Sex Workers in Puerto Rico.
    Giguere R; Frasca T; Dolezal C; Febo I; Cranston RD; Mayer K; McGowan I; Carballo-Diéguez A
    AIDS Behav; 2016 Oct; 20(10):2192-2202. PubMed ID: 27048236
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Developing and Assessing the Feasibility of a Home-based Preexposure Prophylaxis Monitoring and Support Program.
    Siegler AJ; Mayer KH; Liu AY; Patel RR; Ahlschlager LM; Kraft CS; Fish R; Wiatrek SE; Sullivan PS
    Clin Infect Dis; 2019 Jan; 68(3):501-504. PubMed ID: 29982304
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Screening for HIV Infection and Preexposure Prophylaxis for the Prevention of HIV Infection.
    Tracer H; Jasmin W
    Am Fam Physician; 2019 Nov; 100(10):637-638. PubMed ID: 31730313
    [No Abstract]   [Full Text] [Related]  

  • 39. Pre-Exposure Prophylaxis (PrEP) Use and Condomless Anal Sex: Evidence of Risk Compensation in a Cohort of Young Men Who Have Sex with Men.
    Newcomb ME; Moran K; Feinstein BA; Forscher E; Mustanski B
    J Acquir Immune Defic Syndr; 2018 Apr; 77(4):358-364. PubMed ID: 29210834
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trends in condom use among MSM in the United States: the role of antiretroviral therapy and seroadaptive strategies.
    Paz-Bailey G; Mendoza MC; Finlayson T; Wejnert C; Le B; Rose C; Raymond HF; Prejean J;
    AIDS; 2016 Jul; 30(12):1985-90. PubMed ID: 27149088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.